content

Turkish Cargo is steering the future of the industry with the digital event “Cargo Talks”

Turkish Cargo is organizing a webinar titled “Cargo Talks” during which the valuable stakeholders of the air cargo industry, who finger on the pulse...

Vaxart Announces Positive Preliminary Data from Phase 1 Clinical Trial Evaluating Its Oral COVID-19 Tablet Vaccine Candidate

Vaxart, Inc., a clinical-stage biotechnology company developing oral vaccines administered by tablet, announced preliminary data from its Phase 1 study of VXA-CoV2-1 showing that...

CSafe Global Continues Expansion Across Asia with Two New Hub Locations in China

CSafe Global, the innovation leader in temperature-controlled container solutions for the transport of life-enhancing pharmaceuticals, continues to expand operations across Asia opening two new...

GSK and CureVac to develop next generation mRNA COVID-19 vaccines

GlaxoSmithKline plc and CureVac N.V. announced a new €150m collaboration, building on their existing relationship, to jointly develop next generation mRNA vaccines for COVID-19...

Oxford leads first trial investigating dosing with alternating vaccines

The University of Oxford is to lead the first trial to explore alternating different COVID-19 vaccines, to explore the potential for flexibility in delivery...

Metrics Contract Services Appoints New VP of Business Development

Metrics Contract Services, a full-service contract development and manufacturing organization (CDMO) in novel oral solid dose products, has appointed Britton Jimenez as Vice President...

Abzena selected to develop and manufacture antibody cocktail for Immunome’s COVID-19 Antibody Based Treatment

Immunome, Inc., a biopharmaceutical company utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics, and Abzena, a partner...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read